According to Health Minister Silvia Lutucuta, the vaccine is a highly effective and safe weapon. She did not specify which of the two immunogens approved by the World Health Organization (WHO) will be introduced in the country.
In statements to the Angola Press news agency, she pointed out that both RTS,S (Mosquirix) and R21/Matrix-M are intended for children and are administered in a four-dose regimen. The government is therefore preparing to carry out this initiative, which should reduce the incidence of the disease.
She added that it will also contribute to strengthening the Angolan health system, which achieved a significant reduction in malaria cases in the first half of 2025, dropping from approximately 10 million in 2024 to 6.9 million this year, primarily thanks to early detection and treatment.
Lutucuta emphasized that malaria “cannot be addressed solely from a health perspective,” as its prevalence is also influenced by factors such as basic sanitation and health education.
Therefore, in addition to the vaccine, efforts are underway to strengthen epidemiological surveillance and laboratory capacity throughout the country, with the reference network expected to expand to 12 provinces.
Likewise, the creation of Public Health Emergency Operations Centers (COESP) is projected for the first half of 2026, all of which will enhance the capacity to respond to emergency situations.
jdt/jav/mem/kmg
